Page last updated: 2024-10-26

enoxacin and Malignant Melanoma

enoxacin has been researched along with Malignant Melanoma in 1 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Research Excerpts

ExcerptRelevanceReference
"Not only in melanoma, but also in MCF7 breast carcinoma and A2780 ovarian carcinoma cells overexpressing MdmX."1.46A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein. ( Growkova, K; Mlcochova, J; Radova, L; Slaby, O; Stetkova, M; Uldrijan, S; Valcikova, B; Valianatos, G; Verlande, A; Vyhnakova, M, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valianatos, G1
Valcikova, B1
Growkova, K1
Verlande, A1
Mlcochova, J1
Radova, L1
Stetkova, M1
Vyhnakova, M1
Slaby, O1
Uldrijan, S1

Other Studies

1 other study available for enoxacin and Malignant Melanoma

ArticleYear
A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Alternative Splicing; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; DNA Damage;

2017